VIVACITY-MG: A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE- BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, EFFICACY, PHARMACO-KINETICS, PHARMACODYNAMICS, AND IMMUNOGENICITY OF NIPOCALIMAB ADMINISTERED TO ADULTS WITH GENERALIZED MYASTHENIA GRAVIS

被引：0

作者：

Antozzi, Carlo ^{[1
]}

Guptill, Jeffrey ^{[2
]}

Bril, Vera ^{[3
]}

Gamez, Josep ^{[4
]}

Meuth, Sven G. ^{[5
]}

Blanco, Jose L. M. ^{[6
]}

Nowak, Richard J. ^{[7
]}

Quan, Dianna ^{[8
]}

Sevilla, Teresa ^{[9
]}

Szczudlik, Andrzej ^{[10
]}

Hegarty, Brooke ^{[11
]}

Jouvin, Marie-Helene ^{[11
]}

Jin, Jim ^{[11
]}

Arroyo, Santiago ^{[11
]}

机构：

[1] Fdn Ist Neurol Carlo Besta, Milan, Italy

[2] Duke Univ, Sch Med, Durham, NC USA

[3] Univ Toronto, Div Neurol, Toronto, ON, Canada

[4] Hosp Univ Vall Hebron, Neuromuscular Unit, Barcelona, Spain

[5] Heinrich Heine Univ Dusseldorf, Dusseldorf, Germany

[6] Hosp Gen Univ Gregorio Maranon, Serv Neurol, Madrid, Spain

[7] Yale Univ, Sch Med, New Haven, CT USA

[8] Univ Colorado, Sch Med, Aurora, CO USA

[9] Hosp Univ Politecn La Fe, Valencia, Spain

[10] Jagiellonian Univ, Med Coll, Krakow, Poland

[11] Momenta Pharmaceut, Cambridge, MA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P-119

引用

页码：498 / 498

页数：1